RTI Forethought: Get READDI for the next pandemic Date Published: November 11, 2021 As we struggle to emerge from one pandemic, RTI International is putting at least $5 million into an effort with researchers from…
RTI’s Forethought Research Collaboration Challenge Announces Winner Date Published: November 8, 2021 The winning team will receive $5 million in initial seed funding to accelerate the production of antiviral drugs RTI International,…
North Carolina Has the Nation’s Top State Business Climate in 2021 Date Published: November 1, 2021 Site Selection magazine has named North Carolina as the state with the Top Business Climate in the U.S. The state…
Gene therapy firm picks Durham County for new plant, jobs paying $92.5K Date Published: October 26, 2021 Jaguar Gene Therapy, a developer of treatments targeting what it calls “severe” genetic diseases, will build a new manufacturing facility…
Gene therapy shows promise against neurodevelopment disorder Angelman, UNC scientists report Date Published: October 25, 2021 Scientists at the UNC School of Medicine have reported in the journal JCI Insight encouraging early tests of a gene…
Duke lands $17.5M federal grant to develop next-generation coronavirus vaccine Date Published: October 21, 2021 by Sarah Avery The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to…
Raleigh’s Opus Genetics, with $19M in funding, hires two executives Date Published: October 20, 2021 Opus Genetics, which launched in September with $19 million in funding, is adding to the company’s leadership team, the company…
RTP’s Locus Biosciences secures up to $25M in credit, plans expansion Date Published: October 19, 2021 Locus Biosciences has signed a credit facility deal with Hercules Capital (NYSE: HTGC) worth up to $25 million. According to…
After $100M round, RTP startup Kryia Therapeutics spins out new group focusing on eye diseases Date Published: October 18, 2021 by Chantal Allam, NCBiotech Writer Kriya Therapeutics is launching a new division focused on developing gene therapies for rare and…